Skip to content
Search

Latest Stories

Submit Guest Post

Dr Amir Khan warns omega-3 deficiency impacts memory and mood

TV doctor highlights widespread nutritional gap affecting brain, heart and mood health

Dr Amir Khan warns omega-3 deficiency impacts memory and mood

Dr Khan, who follows a vegetarian diet himself, offered practical solutions for different dietary preferences

Getty Images

Highlights

  • Most people aren't getting enough omega-3 fatty acids despite believing they eat healthily.
  • EPA and DHA are crucial for brain cell communication, concentration and memory.
  • Vegetarians and vegans can obtain omega-3 from algae-based supplements.

Popular television doctor Amir Khan has urged about omega-3 fatty acids, warning that widespread deficiency of this essential nutrient could lead to serious long-term health consequences.

The GP, regularly seen on ITV's Lorraine and Good Morning Britain, took to TikTok to address what he describes as a growing nutritional gap affecting people, even those who consider themselves health conscious.


"Omega-3 fatty acids are essential fats your body can't make, so you have to get them from food," Dr Khan explained.

"They're especially important for our brains but also our heart, our eyes, reducing inflammation and even improving our mood."

The doctor highlighted two critical types of omega-3 - EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) - which are particularly vital for brain health.

According to the Cleveland Clinic, these marine omega-3s, found in fish, differ from ALA (alpha-linolenic acid), the plant-based form.

"DHA is a major building block for the brain. It literally helps your brain cells communicate properly," Dr Khan noted.

"If you're not getting enough over time, that can affect things like your concentration, your memory, your mood and even your long-term brain health."

Dietary solutions

Modern diets present a significant challenge, the doctor noted. Ultra-processed foods high in omega-6 fats now dominate British plates, effectively crowding out beneficial omega-3s.

Meanwhile, consumption of oily fish such as salmon, sardines and mackerel remains low.

Dr Khan, who follows a vegetarian diet himself, offered practical solutions for different dietary preferences.

Fish eaters should aim for oily fish twice weekly, while those avoiding fish can turn to algae-based supplements, which provide EPA and DHA directly.

"Fish don't actually make their own omega-3s, they get them from algae in the ocean," he revealed.

Plant sources including flax seeds, chia seeds and walnuts contain ALA, though the body must work harder to convert this into EPA and DHA.

The doctor warned that prolonged omega-3 deficiency has been linked to increased inflammation, heart disease risk, mood disorders, accelerated brain ageing and adverse pregnancy outcomes.

"Think of omega-3s as brain nutrition, not just a wellness trend," Dr Khan concluded.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less